METASTASIS PROSTATE ADENOCARCINOMA

Clinical trials for METASTASIS PROSTATE ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new METASTASIS PROSTATE ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for METASTASIS PROSTATE ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New Triple-Threat attack on spreading prostate cancer

Disease control Ongoing

This study is testing whether adding an immunotherapy drug (nivolumab) to standard hormone therapy and chemotherapy can better control prostate cancer that has already spread. It is for men newly diagnosed with a high amount of spreading cancer. The goal is to see if this three-d…

Matched conditions: METASTASIS PROSTATE ADENOCARCINOMA

Phase: PHASE2 • Sponsor: Xiao X. Wei, MD • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

METASTASIS PROSTATE ADENOCARCINOMA

Get alerted when new METASTASIS PROSTATE ADENOCARCINOMA trials appear

New Triple-Threat attack on spreading prostate cancer